Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2026 ∙ Lihemo, G. Blunt, M. Dadari, I. Underwood, T. Ochoa Toasa, A. E. Velias, A. Hopkins, K. L. Thomson, A. Kanwagi, R. Gillespie, A. Pokharel, D. R. Singh, S.

The impact of COVID-19 on general vaccine acceptance in low- and middle-income countries: a systematic review

  • All age groups
  • Low and Middle Income Countries
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Lopes, J. R. Martins Esteves, I. Dias, S. O. da Silva, F. M. T. D. F. G. da Silva, G. C. D. M. Libonati, N. B. Gasparetti, R. M. Nau, A. L.

The impact of maternal respiratory syncytial virus vaccination on infant and perinatal outcomes: a systematic review and meta-analysis of randomized controlled trials

  • Adults
  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2026 ∙ Rosso, A. Riccio, M. Renzi, E. Patania, F. Baccolini, V. Kaisy, A. M. Marzuillo, C. De Vito, C. Villari, P. Massimi, A.

The role of school-based health education in promoting childhood and adolescent vaccination: A systematic review and Meta-analysis

  • Children
  • Adolescents
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Kling, K. Falman, A. Branke, L. Ramharter, M. Rothe, C. Schonfeld, C. Grunewald, T.

Vaccination against chikungunya - a systematic review on the immunogenicity, tolerability, and safety of the live-attenuated vaccine (LAV) Ixchiq and the virus like particle (VLP) vaccine Vimkunya

  • All age groups
  • Chikungunya
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2026 ∙ Pascucci, D. Lontano, A. Crovella, S. Cosci, S. Laurenti, P.

Vaccination coverage among individuals receiving HIV pre-exposure prophylaxis (PrEP): A systematic review and meta-analysis

  • All age groups
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Alhumaid, S. Alkhars, O. Algrafi, A. S. Dossary, N. A. Elhaj, N. Majzoub, R. A. Turkistani, J. A. Alhumaid, S. M. Shaikh, H. A. A. Aldiaram, A. Alahmed, A. H. Alomran, S. A. AlQatifi, M. B. Alkolib, M. J. Almubarak, M. S. Al-Helal, H. Alhaddad, A. J. Alsouaib, H. A. Albahrani, A. A. Aldera, A. H. Alnasser, F. M. Alhmeed, N. Alsulaiman, M. S. Al Alawi, Z. Alghazal, H. A.

Vaccine effectiveness across the Omicron evolutionary spectrum (BA.2, BA.5, XBB, JN.1, KP.3): a systematic review of studies published 2022-2025

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
High
2026 ∙ Lertussavavivat, T. Isaranuwatchai, S. Eiam-Ong, S. Praditpornsilpa, K. Susantitaphong, P.

Vaccine efficacy in CKD patients not on dialysis: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Hepatitis B
  • COVID-19
  • Influenza
  • Pneumococcal disease
  • Herpes zoster
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2026 ∙ Landicho, J. Bravo, T. A. Wachinger, J. Silvestre, C. Barnighausen, K. Scott, K. Barnighausen, T. McMahon, S. A. Renosa, M. D. C.

Vaccine preferences and their role for vaccine confidence and uptake: a meta-ethnography

  • All age groups
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Valente, C. F. C. Giamberardino, H. I. G. Petraglia, T. C. M. B. Salviano, C. F. Gomes, P. L. Pontes, R. M. Canellas de Castro, M. E. Antonelli, L. R. V. Martins-Filho, O. A. Albuquerque, C. P. Mota, L. M. H.

Vaccine-Induced Immunity in Children and Adolescents After Chemotherapy for Acute Lymphoblastic Leukemia: A Systematic Review

  • Newborn
  • Children
  • Adolescents
  • Diphtheria
  • Pertussis
  • Tetanus
  • Poliomyelitis
  • Haemophilus influenzae type B
  • Measles
  • Mumps
  • Rubella
  • Influenza
  • Varicella
  • Yellow fever
  • Pneumococcal disease
  • Meningococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Liu, C. Ng, T. J. Mansuri, S. Ghonaim, N. Roy, D. Moshi, U. Chen, A. C. C.

Video-based interventions to promote HPV vaccination among individuals aged 9 to 26: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...